Pasar al contenido principal

SINGLE-CELL IMMUNOPHENOTYPIC AND TRANSCRIPTOMIC PROFILING FOR MINIMALLY-INVASIVE DETECTION OF EARLY MULTIPLE MYELOMA

AC17/00101

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Acciones Complementarias de Programación Conjunta Internacional
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
Centro realización CLINICA UNIVERSIDAD DE NAVARRA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

  • Botta, Cirino
  • Perez, Cristina|||0000-0003-3586-2666
  • Larrayoz, Marta|||0000-0001-6097-8244
  • Puig, Noemí|||0000-0001-7535-3861
  • Cedena, María Teresa|||0000-0001-5851-3720
  • Termini, Rosalinda
  • Goicoechea, Ibai|||0000-0002-5329-2225
  • Rodriguez, Sara|||0000-0001-6509-0447
  • Zabaleta, Aintzane|||0000-0003-3474-3040
  • Lopez, Aitziber
  • Sarvide, Sarai
  • Blanco Fernández, Laura|||0000-0002-1859-0884
  • Papetti, Daniele Marco|||0000-0002-3574-6027
  • Nobile, M.S.
  • Besozzi, Daniela
  • Gentile, Massimo
  • Correale, Pierpaolo
  • Siragusa, Sergio
  • Oriol, Albert|||0000-0001-6804-2221
  • González Garcia, Maria Esther|||0000-0002-4238-0377
  • Sureda, Anna|||0000-0002-1238-6970
  • De Arriba, Felipe|||0000-0002-4451-1318
  • Ríos-Tamayo, Rafael|||0000-0001-8193-1402
  • Moraleda, José María|||0000-0001-9080-1466
  • Gironella, Mercedes|||0000-0002-8106-8909
  • Hernández, Miguel Teodoro|||0000-0002-6576-7881
  • Bargay, Joan|||0000-0002-6739-3916
  • Palomera, Luís
  • Pérez-Montaña, Albert
  • Goldschmidt, Hartmut|||0000-0003-0961-0035
  • Avet-Loiseau, Hervé
  • Roccaro, Aldo|||0000-0002-1872-5128
  • Orfao, Alberto|||0000-0002-0007-7230
  • Martinez-Lopez, Joaquín
  • Rosiñol, Laura|||0000-0002-2534-9239
  • Lahuerta, J. J.|||0000-0002-3393-9570
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • Mateos, M. V.|||0000-0003-2390-1218
  • San Miguel, Jesús|||0000-0002-9183-4857
  • Martinez Climent, Juan-José|||0000-0002-7938-3950
  • Paiva, Bruno|||0000-0003-1977-3815
Tumor recognition by T cells is essential for antitumor immunity. A comprehensive characterization of T cell diversity may be key to understanding the success of immunomodulatory drugs and failure of PD-1 blockade in tumors such as multiple myeloma (MM). Here, we use single-cell RNA and T cell receptor sequencing to characterize bone marrow T cells from healthy adults (n = 4) and patients with precursor (n = 8) and full-blown MM (n = 10). Large T cell clones from patients with MM expressed multiple immune checkpoints, suggesting a potentially dysfunctional phenotype. Dual targeting of PD-1 + LAG3 or PD-1 + TIGIT partially restored their function in mice with MM. We identify phenotypic hallmarks of large intratumoral T cell clones, and demonstrate that the CD27 and CD27 T cell ratio, measured by flow cytometry, may serve as a surrogate of clonal T cell expansions and an independent prognostic factor in 543 patients with MM treated with lenalidomide-based treatment combinations.